BioSpace News Archive

Lupin Pharmaceuticals Inc. (Lupin) today announced positive top-line results from its pivotal Phase 3 clinical trial to assess efficacy and safety of single-dose Solosec® (secnidazole) 2g oral granules in 147 female patients with trichomoniasis.

Median Technologies is announcing that on March 30, 2020, it concluded a new liquidity contract with the Company Louis Capital Markets in accordance with the Amafi charter.

Stallergenes Greer, a biopharmaceutical company specialising in treatments for respiratory allergies, announces the submission of a marketing authorisation application for STAGR320, its sublingual house dust mite immunotherapy tablet, via a European decentralized procedure.

Research Published in Nature Communications is Initial Step Towards Developing Fully Human Antibody Therapeutics and Diagnostics for Respiratory Disease COVID-19

Amphastar Pharmaceuticals, Inc. announced that the Company will release results for its first quarter of 2020 ended March 31, 2020, after the market closes on Thursday, May 7th, 2020, and will hold a conference call to discuss its financial results at 2:00 p.m. Pacific Time..

Oragenics, Inc.,, announced its acquisition of Noachis Terra Inc., following its entry into a stock purchase agreement, to develop and commercialize TerraCoV2, a vaccine candidate which could provide specific immunity from the novel coronavirus, the root cause of coronavirus disease 2019.

Kidney care company supports patients with award-winning education and daily updates

Ascentage Pharma, a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B, and age-related diseases, announced that the US Food and Drug Administration has granted HQP1351, the Company’s core drug candidate, an Orphan Drug Designation for the treatment of chronic myeloid leukemia.

Teleflex Incorporated announced that its Board of Directors declared a quarterly cash dividend of thirty-four cents per share of common stock.

, a clinical-stage biopharmaceutical company, announced that the Company will host a conference call and live audio webcast on Monday, May 11, 2020 at 4:30 p.m. ET to discuss operational and financial results for the first quarter ended March 31, 2020..